EQUILLIUM, INC. Other Noncash Income (Expense)
EQUILLIUM, INC. (EQ) reported Other Noncash Income (Expense) of $20.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2020-03-26
- EQUILLIUM, INC. other noncash income (expense) for the quarter ending 2018-12-31 was -$228.51K.
- EQUILLIUM, INC. other noncash income (expense) for the quarter ending 2018-09-30 was -$1.22M.
- EQUILLIUM, INC. other noncash income (expense) for the quarter ending 2018-06-30 was -$619.00K.
- EQUILLIUM, INC. other noncash income (expense) for the quarter ending 2018-03-31 was -$489.00K.
- EQUILLIUM, INC. other noncash income (expense) for fiscal 2019 was $20.00K.
- EQUILLIUM, INC. other noncash income (expense) for fiscal 2018 was -$2.56M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 7 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 10 month | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | $20.00K 10-K · filed 2020-03-26 | ||||||
| 2018-12-31 | -$228.51K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | -$1.45M derived: sum of 2 quarters · filed 2019-11-12 | -$2.07M derived: sum of 3 quarters · filed 2019-11-12 | -$2.56M 10-K · filed 2019-03-27 | |||
| 2018-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.84M derived: sum of 2 quarters · filed 2019-11-12 | -$2.33M 10-Q · filed 2019-11-12 | -$2.33M 10-Q · filed 2018-11-15 | |||
| 2018-06-30 | -$619.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$1.11M 10-Q · filed 2019-08-12 | |||||
| 2018-03-31 | -$489.00K 10-Q · filed 2019-05-13 | ||||||
| 2017-12-31 | -$379.38K 10-K · filed 2019-03-27 | ||||||
| 2017-09-30 | -$22.19K 10-Q · filed 2018-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |